Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
342
datasets available to search
ShareScore release 0.9.0
Dataset results
342 results for “biliary tract”
Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.
ClinicalTrials.gov study NCT04720131. IPD Sharing: UNDECIDED. Countries: 1. Publications: 17.
Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
ClinicalTrials.gov study NCT02829918. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)
ClinicalTrials.gov study NCT03111732. IPD Sharing: NO. Countries: 1. Publications: 4.
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
ClinicalTrials.gov study NCT04683939. IPD Sharing: NO. Countries: 2. Publications: 1.
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
ClinicalTrials.gov study NCT00361231. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT02711553. IPD Sharing: YES. Countries: 18. Publications: 1.
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer
ClinicalTrials.gov study NCT04072445. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04677504. IPD Sharing: YES. Countries: 13. Publications: 2.
BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT01679405. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT03785873. IPD Sharing: YES. Countries: 1. Publications: 1.
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT03768414. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)
ClinicalTrials.gov study NCT00661830. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China E
ClinicalTrials.gov study NCT04924062. IPD Sharing: YES. Countries: 1. Publications: 1.
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
ClinicalTrials.gov study NCT03833661. IPD Sharing: YES. Countries: 9. Publications: 3.
Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)
ClinicalTrials.gov study NCT04003636. IPD Sharing: YES. Countries: 24. Publications: 4.
Low Dose ICG for Biliary Tract and Tumor Imaging
ClinicalTrials.gov study NCT04942665. IPD Sharing: NO. Countries: 1. Publications: 1.
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer
ClinicalTrials.gov study NCT00107536. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT00753675. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer
ClinicalTrials.gov study NCT03101566. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers
ClinicalTrials.gov study NCT01943864. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.